Chelsea Therapeutics

Lundbeck Completes Acquisition of Chelsea Therapeutics; NORTHERA™ (droxidopa) is expected to be available to patients in the U.S. during the fall of this year
Yahoo
Tue, 06/24/14 - 10:26 am
Lundbeck
Chelsea Therapeutics
Northera
neurogenic orthostatic hypotension
Chelsea Therapeutics - Going Private Transaction Provides Significant Upside
Seeking Alpha
Thu, 05/29/14 - 09:35 am
Chelsea Therapeutics
Lundbeck
This Week in Biotech: Chelsea Therapeutics Finds a Buyer While Corcept Implodes
Motley Fool
Sat, 05/10/14 - 12:45 pm
Chelsea Therapeutics
Corcept Therapeutics
Lundbeck
Theravance
GSK
AstraZeneca
Amgen
Lundbeck to acquire Chelsea Therapeutics for up to $658 mln
Reuters
Thu, 05/8/14 - 08:33 am
Lundbeck
Chelsea Therapeutics
M&A
Better Buyout Candidate: Chelsea Therapeutics International Ltd. vs. InterMune Inc.
Motley Fool
Mon, 03/17/14 - 05:05 pm
Chelsea Therapeutics
Northera
Esbriet
idiopathic pulmonary fibrosis
InterMune
Chelsea Therapeutics Wins FDA Approval For Northera
TheStreet.com
Tue, 02/18/14 - 05:42 pm
FDA
Northera
Chelsea Therapeutics
neurogenic orthostatic hypotension
Chelsea Therapeutics: The Good, The Bad And The Ugly
Seeking Alpha
Thu, 02/13/14 - 09:12 am
Chelsea Therapeutics
FDA
Northera
Prediction: Chelsea Wins Northera FDA Approval Friday
TheStreet.com
Wed, 02/12/14 - 09:48 am
Chelsea Therapeutics
Northera
FDA
3 Companies Working on Parkinson's Treatments You Ought to Know About
Motley Fool
Wed, 01/29/14 - 05:42 pm
Parkinson's Disease
Chelsea Therapeutics
Prothena
Avanir
AVP-923
Northera
PRX-002
Chelsea Therapeutics May Be A Revenue Generating Biotech By The End Of 2014
Seeking Alpha
Fri, 01/17/14 - 08:36 am
Chelsea Therapeutics
Northera
Chelsea Wins U.S. Panel’s Backing for Northera
Bloomberg
Wed, 01/15/14 - 09:29 am
Chelsea Therapeutics
FDA
advisory panels
Northera
neurogenic orthostatic hypotension
Chelsea Therapeutics: Northera FDA Panel Live Blog
TheStreet.com
Tue, 01/14/14 - 09:09 am
FDA
advisory panels
Chelsea Therapeutics
Northera
neurogenic orthostatic hypotension
Shares of Chelsea Therapeutics Sink Ahead of FDA Review
Wall St Cheat Sheet
Sat, 01/11/14 - 08:01 am
Chelsea Therapeutics
Northera
FDA
Biotechs With Near-Term Catalysts That Should Rally
Seeking Alpha
Fri, 01/10/14 - 10:34 am
Ampio
Avanir
Chelsea Therapeutics
Endo Health Solutions
Optina
Northera
Synergy Pharmaceuticals
plecanatide
AVP-825
vintafolide
Long-term efficacy of Chelsea drug may pose problems for FDA
Yahoo/Reuters
Fri, 01/10/14 - 10:07 am
Chelsea Therapeutics
FDA
Northera
Droxidopa
neurogenic orthostatic hypotension
2014 Biotechnology Catalysts
Seeking Alpha
Fri, 01/10/14 - 08:14 am
Chelsea Therapeutics
Durect Corporation
EXACT Sciences
Vanda
Pozen
Progenics
MannKind
FDA
2 Biotech Stocks Facing Major Catalysts in 2014
Wall St Cheat Sheet
Tue, 12/3/13 - 09:23 am
Lion Biotechnologies
Chelsea Therapeutics
Northera
metastatic melanoma
2014 FDA Drug Approval Decision Calendar
TheStreet.com
Wed, 11/27/13 - 08:39 am
FDA
drug approvals
GSK
Gilead
Theravance
Auxilium
Amarin
Bristol-Myers Squibb
Biogen Idec
Pozen
Vanda
Chelsea Therapeutics
pSivida
Alimera
United Therapeutics
Biomarin
JNJ
Pharmacyclics
Celgene
MannKind
Santarus
AstraZeneca
Durata Therapeutics
Eli Lilly
Omeros
BioDelivery Sciences
Anacor
Keryx
Cubist Pharmaceuticals
Nektar
Chelsea Therapeutics Minor NDA Deficiencies Create Opportunity For Huge Gains
Seeking Alpha
Tue, 08/27/13 - 09:34 am
Chelsea Therapeutics
Northera
Parkinson's Disease
Chelsea's NDA for Northera Accepted
Yahoo/Zacks
Sat, 07/20/13 - 11:09 am
Chelsea Therapeutics
Northera
neurogenic orthostatic hypotension

Pages